
Photo taken from Video Journal of Hematology and Hematological Oncology/LinkedIn
Dec 31, 2023, 12:04
Key updates in the treatment and management of myeloproliferative neoplasms – Video Journal of Hematology and Hematological Oncology
Quoting Video Journal of Hematology and Hematological Oncology on LinkedIn:
“NEW MPN Session from ASH23.
This EXCLUSIVE discussion features leading experts Ruben Mesa, Claire Harrison and Jean-Jacques Kiladjian, who discuss key updates in the treatment and management of myeloproliferative neoplasms (MPNs) following the 65th ASH Annual Meeting and Exposition
The experts cover a variety of topics, including novel agents being explored in essential thrombocythemia (ET), updates in the treatment of polycythemia vera (PV), and novel combinations being evaluated in myelofibrosis (MF).
Take a look here.”
Source: Video Journal of Hematology and Hematological Oncology/LinkedIn
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Feb 21, 2025, 15:06
Feb 21, 2025, 14:27
Feb 21, 2025, 14:13
Feb 21, 2025, 13:29